Cargando…
Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker
Analysis of circulating tumour DNA (ctDNA), as one type of ‘liquid biopsy’, has recently attracted great attention. Researchers are exploring many potential applications of liquid biopsy in many different types of cancer. In particular, it is of biological interest and clinical relevance to study th...
Autores principales: | Lam, Wai Kei Jacky, Chan, Kwan Chee Allen, Lo, Yuk Ming Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594142/ https://www.ncbi.nlm.nih.gov/pubmed/30714167 http://dx.doi.org/10.1002/path.5249 |
Ejemplares similares
-
The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015) -
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
por: Lam, W. K. Jacky, et al.
Publicado: (2019) -
Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
por: Chan, K.C. Allen
Publicado: (2014) -
Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy
por: Vo, Jess Honganh, et al.
Publicado: (2016) -
Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
por: Lam, W. K. Jacky, et al.
Publicado: (2018)